A granted patent is not the final word. Every major patent system provides mechanisms for third parties to challenge the validity of granted patents -- and for patent owners to defend them. These post-grant proceedings exist because patent offices, despite rigorous examination, sometimes grant patents that should not have been granted. Prior art gets missed. Claims are allowed that are too broad. Specifications fail to disclose the invention adequately. Post-grant challenges are the quality control layer that corrects these errors without requiring full-blown litigation.
Understanding post-grant proceedings is essential from both sides. If a competitor holds a patent that blocks your product, knowing how and when to challenge it can save you from expensive licensing deals or design-arounds. If you hold a patent that gets challenged, knowing how to mount an effective defense can mean the difference between maintaining your competitive moat and losing it entirely. This chapter covers the major post-grant challenge mechanisms across the world's key patent offices, compares their procedures and strategic implications, and provides defensive strategies for building patents that withstand scrutiny.
Why Post-Grant Challenges Exist
Patent offices operate under constraints. Examiners have limited time per application -- typically 15 to 25 hours across the entire prosecution lifecycle. They search prior art databases that, while extensive, do not capture every relevant publication, product disclosure, trade show demonstration, or foreign-language reference. The examination process is inherently ex parte: the examiner and the applicant engage in a dialogue without any adversarial input from competitors or the public.
This system works well in aggregate -- the vast majority of granted patents are valid. But edge cases accumulate, and in commercially significant technology areas, even a small error rate produces patents that distort competition or block legitimate innovation.
Post-grant challenges address three specific problems:
Quality control. They allow the discovery and correction of examination errors after the patent has been granted. Prior art that the examiner never saw can be brought forward. Claim scope that appeared reasonable during prosecution can be tested against the full landscape of existing technology.
Clearing patent thickets. In technology-dense fields like semiconductors, telecommunications, and software, overlapping patent portfolios create "thickets" that make it difficult for any company to operate without infringing someone's patents. Post-grant challenges provide a mechanism to prune invalid or overbroad patents from these thickets, reducing transaction costs and enabling competition.
Competitive defense. When a competitor obtains a patent that threatens your product line, post-grant proceedings offer a faster, cheaper, and more focused alternative to invalidity defenses raised in district court litigation. The cost of an EPO opposition is a fraction of the cost of patent litigation in any jurisdiction. Even USPTO PTAB proceedings, while more expensive than EPO oppositions, cost a fraction of full patent trial litigation.
EPO Opposition
The EPO opposition procedure is one of the most well-established and widely used post-grant challenge mechanisms in the world. It is a centralized administrative proceeding conducted by the EPO itself -- the same office that granted the patent.
Filing Window and Standing
Any person except the patent proprietor may file an opposition within nine months of the date the mention of grant is published in the European Patent Bulletin. This nine-month window is a hard deadline -- once it closes, the only way to challenge the patent at the EPO is through a limitation or revocation request by the patent owner, or through national court proceedings in individual countries. There is no standing requirement beyond the exclusion of the patent proprietor: competitors, non-practicing entities, trade associations, and even individuals with no commercial interest in the patent may file.
The opposition fee is EUR 880, making it one of the most cost-effective post-grant mechanisms available anywhere. Total professional costs for a straightforward opposition typically range from EUR 15,000 to EUR 50,000, depending on complexity and whether oral proceedings are held.
Grounds for Opposition
Opposition can only be based on three grounds specified in Article 100 EPC. These are not discretionary -- if the challenge does not fit within one of these categories, the opposition division will not consider it.
| Ground | EPC Article | What It Covers | Common Arguments |
|---|---|---|---|
| Lack of patentability | Art. 100(a), referencing Art. 52-57 | The invention lacks novelty, inventive step, or is excluded subject matter | Prior art publications, public prior use, obvious combinations |
| Insufficient disclosure | Art. 100(b) | The patent does not disclose the invention clearly and completely enough for reproduction by a skilled person | Missing essential parameters, undue experimentation required, breadth of claims exceeds what specification enables |
| Added subject matter | Art. 100(c) | The patent as granted contains matter extending beyond the content of the application as originally filed | Claims include features not derivable directly and unambiguously from the original filing |
Art. 100(a) dominates. In practice, the overwhelming majority of oppositions are based on lack of novelty or inventive step under Article 100(a). Insufficiency (Art. 100(b)) and added matter (Art. 100(c)) are raised less frequently as standalone grounds but are often included alongside Art. 100(a) arguments as secondary attacks. A well-constructed opposition notice typically raises Art. 100(a) as the primary ground with the strongest prior art, supported by Art. 100(b) or 100(c) arguments where the patent's drafting creates vulnerabilities.
The Opposition Process
The opposition proceeds through several defined stages:
Filing the notice of opposition. The opponent files a written notice within the nine-month window, specifying the grounds of opposition and providing all facts, evidence, and arguments on which the opposition is based. This is not a placeholder filing -- the EPO requires that the notice be substantively complete. Evidence filed after the opposition period may be admitted at the opposition division's discretion, but late-filed evidence faces an increasingly high admissibility bar.
Patent proprietor's response. The proprietor has an opportunity to respond in writing, defending the patent as granted or filing amended claims. The proprietor may file auxiliary requests -- alternative sets of claims in decreasing order of scope -- as fallback positions.
Further written rounds. The opposition division may invite additional submissions from both parties. In multi-party oppositions (where several opponents have filed against the same patent), coordination of arguments and evidence becomes more complex.
Oral proceedings. Either party may request oral proceedings, and the opposition division may summon them on its own initiative. Oral proceedings are held at the EPO in Munich (or occasionally The Hague) and typically last one day. They are the stage where the opposition division asks probing questions, hears arguments on contested points, and reaches a decision. Many experienced practitioners consider oral proceedings essential for any genuinely contested opposition.
Decision. The opposition division issues a written decision, which can take one of three forms: the opposition is rejected and the patent is maintained as granted; the patent is maintained in amended form (based on one of the proprietor's auxiliary requests); or the patent is revoked.
EPO opposition process from filing through decision and potential appeal. Oral proceedings are common in contested cases and typically last one day.
Opposition Statistics
EPO opposition data reveals important patterns for strategic planning:
| Metric | Approximate Figure |
|---|---|
| Opposition rate (patents opposed / patents granted) | 3-4% |
| Oppositions filed per year | 3,000-4,000 |
| Patents surviving opposition (maintained as granted or amended) | Approximately two-thirds |
| Patents revoked in opposition | Approximately one-third |
| Average duration of proceedings | 2-3 years |
| Oppositions proceeding to oral proceedings | Approximately 60-70% |
| Opposition fee | EUR 880 |
The two-thirds survival rate is sometimes cited as evidence that the system is working well -- most granted patents withstand challenge. But the one-third revocation rate means that a meaningful proportion of opposed patents were incorrectly granted, validating the need for the opposition mechanism.
The nine-month clock starts at grant publication, not at the decision to grant. The EPO publishes the mention of grant in the European Patent Bulletin, and the nine-month opposition period runs from that publication date. If you are monitoring a competitor's pending European patent application, set alerts for the grant publication -- not the Rule 71(3) communication (intention to grant) -- because the deadline runs from publication. Missing the window by even one day permanently forecloses the EPO opposition route.
USPTO PTAB Proceedings
The United States provides several post-grant challenge mechanisms administered by the Patent Trial and Appeal Board (PTAB), a tribunal within the USPTO. The two primary vehicles are Inter Partes Review (IPR) and Post-Grant Review (PGR). A third, older mechanism -- ex parte reexamination -- remains available but is used less frequently since the America Invents Act (AIA) created the IPR and PGR proceedings in 2012.
Inter Partes Review (IPR)
IPR is the most commonly used PTAB proceeding. It allows a petitioner to challenge the validity of one or more claims of an issued patent on the grounds of anticipation (lack of novelty) or obviousness, based only on prior art consisting of patents and printed publications.
Filing window. An IPR petition can be filed at any time after the nine-month post-grant review window has closed (or after termination of any PGR proceeding). There is no outer time limit, but if the patent owner has filed an infringement action, the petitioner must file the IPR within one year of being served with the complaint.
Institution decision. Unlike EPO opposition, where a properly filed opposition is automatically considered on the merits, IPR petitions must survive a threshold inquiry. The PTAB decides whether to "institute" the proceeding based on whether the petition demonstrates a reasonable likelihood that the petitioner will prevail on at least one challenged claim. Approximately 55-65% of IPR petitions are instituted.
Trial. Once instituted, the IPR proceeds as a trial before a three-judge panel of administrative patent judges (APJs). Discovery is limited compared to district court litigation. The proceeding must be completed within 12 months of institution (extendable by 6 months for good cause). The petitioner bears the burden of proving invalidity by a preponderance of the evidence.
Estoppel. A final written decision in an IPR triggers estoppel: the petitioner (and its real parties in interest and privies) cannot assert in subsequent district court litigation or ITC proceedings any ground that it raised or reasonably could have raised during the IPR. This estoppel provision is one of the most strategically significant aspects of IPR and requires careful planning before filing.
Post-Grant Review (PGR)
PGR is a broader but more time-limited proceeding. It allows challenges on any ground of invalidity -- not just anticipation and obviousness based on prior art patents and publications, but also written description, enablement, indefiniteness, subject matter eligibility, and any other statutory ground.
Filing window. PGR must be filed within nine months of patent grant. This window mirrors the EPO opposition period, though the two proceedings are otherwise quite different.
Institution standard. The PTAB will institute PGR if the petition demonstrates that it is more likely than not that at least one challenged claim is unpatentable. This is a higher threshold than IPR's "reasonable likelihood" standard.
Availability. PGR is available only for patents with an effective filing date on or after March 16, 2013 (the AIA effective date). As the remaining pre-AIA patents age out of enforcement relevance, PGR is becoming the standard early-window challenge vehicle.
Ex Parte Reexamination
Ex parte reexamination is the oldest USPTO post-grant mechanism, predating both IPR and PGR. Any person (including the patent owner) can request reexamination based on prior art patents or printed publications that raise a "substantial new question of patentability." The proceeding is conducted between the patent owner and the examiner only -- the requester has no further involvement after filing and receiving the patent owner's response.
Ex parte reexamination is less commonly used today because IPR provides a more robust proceeding with adversarial participation. However, it retains strategic utility in specific situations: when the requester wants to remain anonymous, when the one-year IPR deadline has passed following service of an infringement complaint, or when the challenge is based on a single devastating prior art reference that speaks for itself.
EPO Opposition vs. USPTO PTAB: Side-by-Side Comparison
The following table compares the key features of EPO opposition, USPTO IPR, and USPTO PGR to help practitioners choose the appropriate vehicle for each jurisdiction.
| Feature | EPO Opposition | USPTO IPR | USPTO PGR |
|---|---|---|---|
| Filing window | 9 months from grant publication | After 9-month PGR window closes; 1 year from service of infringement complaint | 9 months from grant |
| Who can file | Any person except patent owner | Any person except patent owner | Any person except patent owner |
| Grounds | Novelty, inventive step, excluded subject matter, insufficiency, added matter | Anticipation and obviousness based on patents/printed publications only | Any ground of invalidity |
| Institution threshold | None (automatically considered on merits) | Reasonable likelihood of prevailing | More likely than not |
| Decision maker | Opposition division (3 technically qualified examiners) | PTAB panel (3 administrative patent judges) | PTAB panel (3 administrative patent judges) |
| Duration | 2-3 years | 12-18 months from institution | 12-18 months from institution |
| Official fees | EUR 880 | USD 19,000-23,000 (petition + post-institution) | USD 20,000-24,000 (petition + post-institution) |
| Standard of proof | Balance of probabilities | Preponderance of evidence | Preponderance of evidence |
| Claim amendment by owner | Allowed (auxiliary requests) | Allowed but rarely granted in practice | Allowed but rarely granted in practice |
| Estoppel | None | Yes -- raised or reasonably could have raised | Yes -- raised or reasonably could have raised |
| Geographic effect of revocation | All designated EPC states | United States only | United States only |
| Appeal route | EPO Boards of Appeal | Court of Appeals for the Federal Circuit | Court of Appeals for the Federal Circuit |
Cost asymmetry matters strategically. An EPO opposition costs EUR 880 in official fees. A USPTO IPR costs roughly USD 20,000 in PTAB fees alone, before attorney costs. This 20:1 fee differential means that EPO opposition is accessible to small companies and even individuals, while IPR is primarily a tool for well-funded entities. When planning a global patent challenge strategy, the EPO opposition route may deliver the highest return on investment because a successful revocation eliminates the patent across all European designated states at minimal official cost.
Third-Party Observations
Not every prior art submission requires a formal opposition or PTAB petition. Several major patent offices allow third parties to submit prior art and observations during the examination process, before the patent is granted. These submissions are informal, low-cost, and often anonymous -- but they can be highly effective at shaping examination outcomes.
EPO Third-Party Observations
Under Article 115 EPC, any third party may file observations on the patentability of an invention that is the subject of a pending European patent application or patent. Observations can be filed at any time during prosecution and even during opposition proceedings. There is no fee, and the third party does not become a party to the proceedings. The EPO examiner or opposition division must consider the observations but is not obligated to act on them.
USPTO Third-Party Preissuance Submissions
Under 35 USC 122(e), any third party may submit patents, published patent applications, and other printed publications relevant to a pending patent application, along with a concise description of the relevance of each document. The submission must be filed before the earlier of (a) the date of a notice of allowance, or (b) the later of six months after publication of the application or the date of the first office action rejection. A fee of approximately USD 180 per submission applies for up to 10 documents.
JPO Information Provision
The Japan Patent Office allows third parties to submit information (prior art documents and arguments) relevant to a pending patent application under Article 13bis of the Examination Guidelines. There is no fee, and the submitter does not become a party to the proceedings.
| Office | Mechanism | Fee | Timing | Anonymity |
|---|---|---|---|---|
| EPO | Third-party observations (Art. 115 EPC) | None | Any time during prosecution or opposition | Yes (can be filed anonymously) |
| USPTO | Preissuance submissions (35 USC 122(e)) | ~USD 180 (up to 10 documents) | Before notice of allowance or 6 months after publication | No (submitter identified) |
| JPO | Information provision (Art. 13bis) | None | During examination | Yes |
| KIPO | Information provision | None | During examination | Yes |
| CNIPA | Public observations | None | During examination | Yes |
Appeals
When a post-grant proceeding produces an unfavorable outcome -- whether for the challenger or the patent owner -- appeals provide a second layer of review. Appeal systems vary significantly across jurisdictions in their structure, scope of review, and practical outcomes.
EPO Boards of Appeal
Decisions of the EPO's opposition divisions can be appealed to the Boards of Appeal, which are judicial bodies within the EPO that are independent of the examining and opposition divisions. Appeal must be filed within two months of notification of the decision, and the statement of grounds of appeal must be filed within four months.
The Boards of Appeal conduct a full review of the case, including both legal and factual issues. They can uphold the opposition division's decision, reverse it, or remit the case back to the opposition division for further consideration. The appeal fee is EUR 2,255.
The Enlarged Board of Appeal sits above the Boards of Appeal and resolves questions of law referred to it by a Board of Appeal (when important points of law arise or when Boards have issued conflicting decisions) or by the President of the EPO. The Enlarged Board does not decide individual cases on their merits -- it answers specific legal questions that are then applied by the referring Board. Landmark Enlarged Board decisions have shaped fundamental aspects of European patent law, including the scope of patentable subject matter, the standard for added matter, and the admissibility of late-filed evidence.
USPTO: Court of Appeals for the Federal Circuit (CAFC)
Final written decisions from the PTAB in IPR and PGR proceedings are appealed to the United States Court of Appeals for the Federal Circuit. The Federal Circuit reviews legal conclusions de novo and factual findings for substantial evidence. Unlike the EPO Boards of Appeal, the Federal Circuit does not re-examine the technical merits itself -- it reviews whether the PTAB applied the correct legal standard and whether substantial evidence supports the PTAB's factual findings.
The Federal Circuit is the exclusive appellate court for patent cases in the United States, and its decisions set binding precedent for all patent matters. An appeal from the Federal Circuit goes to the United States Supreme Court, which accepts only a small number of patent cases each year -- typically those presenting important questions of patent policy.
Asian Appellate Bodies
| Jurisdiction | First-Level Review | Appellate Court | Key Features |
|---|---|---|---|
| Japan | JPO Trial and Appeal Board (invalidation trial) | IP High Court (Tokyo) | De novo review of technical and legal issues; highly specialized bench |
| China | CNIPA Reexamination and Invalidation Department | Beijing IP Court, then Supreme People's Court | Invalidation decisions appealed to Beijing IP Court; significant caseload growth |
| South Korea | KIPO Intellectual Property Trial and Appeal Board (IPTAB) | Patent Court (Daejeon), then Supreme Court | IPTAB handles invalidation trials; Patent Court conducts appellate review |
Appeal pathways from post-grant proceedings across major patent jurisdictions. Each system provides at least two levels of appellate review, though the scope and standard of review differ significantly.
Invalidation in Asia
Asia's three major patent offices -- CNIPA (China), JPO (Japan), and KIPO (South Korea) -- each provide their own post-grant invalidation mechanisms. These proceedings are increasingly important given Asia's growing share of global patent filings and the commercial significance of patent rights in these markets.
China: Invalidation at CNIPA
Any individual or entity may file a request for invalidation of a Chinese patent with the CNIPA Reexamination and Invalidation Department at any time after grant. Unlike the EPO's nine-month opposition window, there is no time limit for filing an invalidation request in China.
Grounds. Invalidation can be requested on any ground under the Chinese Patent Law, including lack of novelty, lack of inventive step (referred to as "creativeness"), insufficient disclosure, claims not supported by the description, amendment beyond the original disclosure, and failure to meet subject matter eligibility requirements.
Process. The Reexamination and Invalidation Department forms a panel (typically three examiners) that conducts a full review, including oral hearings if requested. The panel issues a decision maintaining or invalidating the patent (in whole or in part). The entire process typically takes 6 to 12 months -- significantly faster than most other jurisdictions.
Appeal. Invalidation decisions are appealed to the Beijing Intellectual Property Court and then, if necessary, to the Supreme People's Court.
Strategic note. Chinese invalidation proceedings are frequently used as defensive tactics in patent infringement disputes. When a patent owner files an infringement action in a Chinese court, the defendant commonly files an invalidation request at CNIPA in parallel. Chinese courts may (but are not required to) stay the infringement proceedings pending the outcome of the invalidation request.
Japan: Invalidation Trial at JPO
Any interested party may file an invalidation trial request at the JPO at any time after grant. The JPO Trial and Appeal Board conducts the invalidation trial, which is a formal inter partes proceeding between the petitioner and the patent owner.
Grounds. Invalidation can be requested on any ground of invalidity under the Japanese Patent Act, including lack of novelty, lack of inventive step, insufficient disclosure, lack of support, and violation of the first-to-file rule.
Process. The Trial and Appeal Board appoints a panel of three or five administrative judges who conduct the proceeding through written submissions and, where necessary, oral hearings. The patent owner may file corrected claims (the Japanese equivalent of claim amendments). The proceeding typically takes 12 to 18 months.
Appeal. Decisions of the Trial and Appeal Board are appealed to the IP High Court in Tokyo, which conducts a de novo review of both factual and legal issues. The IP High Court is one of the most technically sophisticated patent appellate courts in the world, with judges who have deep technical backgrounds.
South Korea: Invalidation Trial at KIPO
Any interested party may file an invalidation trial at the Korean Intellectual Property Trial and Appeal Board (IPTAB). The structure closely mirrors the Japanese system.
Grounds. All statutory grounds of invalidity under the Korean Patent Act, including lack of novelty, lack of inventive step, insufficient disclosure, and expanded scope of claims beyond the original application.
Process. The IPTAB appoints a panel of three to five judges who review the case through written submissions and oral proceedings. The patent owner may file corrected claims. Duration is typically 9 to 14 months.
Appeal. IPTAB decisions are appealed to the Patent Court in Daejeon, and further to the Supreme Court of Korea.
Asian Invalidation Comparison
| Feature | China (CNIPA) | Japan (JPO) | South Korea (KIPO) |
|---|---|---|---|
| Filing window | Any time after grant | Any time after grant | Any time after grant |
| Standing | Any person or entity | Interested party | Interested party |
| Grounds | All statutory grounds | All statutory grounds | All statutory grounds |
| Decision maker | Reexamination and Invalidation Department (3-member panel) | Trial and Appeal Board (3-5 judges) | IPTAB (3-5 judges) |
| Claim amendment by owner | Limited corrections allowed | Corrected claims allowed | Corrected claims allowed |
| Typical duration | 6-12 months | 12-18 months | 9-14 months |
| Official fees | Approximately CNY 3,000 (~USD 420) | Approximately JPY 50,000 (~USD 340) | Approximately KRW 150,000 (~USD 115) |
| Appeal route | Beijing IP Court, then Supreme People's Court | IP High Court (Tokyo), then Supreme Court | Patent Court (Daejeon), then Supreme Court |
No time limit is a double-edged sword. Unlike the EPO's nine-month opposition window, the Asian offices allow invalidation requests at any time during the patent's life. This means a patent owner faces the perpetual risk of challenge, even years after grant. For challengers, however, the open window provides strategic flexibility -- you can time an invalidation request to coincide with infringement litigation or licensing negotiations. From a defensive perspective, patent owners in Asia must build patents that can withstand scrutiny not just at grant but throughout the entire patent term.
Defensive Strategies: Building Patents That Survive Challenge
Understanding how post-grant challenges work is only half the equation. The other half is building patents that are resilient to challenge from the outset. The strongest patents are not just those that survive examination -- they are those that are deliberately constructed to withstand opposition, IPR, and invalidation proceedings.
Build a Strong Prosecution Record
The prosecution history is the first place an opponent or petitioner will look for ammunition. Ambiguous claim amendments, inconsistent arguments, and unsupported narrowing of claim scope during prosecution create vulnerabilities that challengers exploit in post-grant proceedings.
- Be consistent in claim interpretation. If you argue to the examiner that a claim term has a specific meaning to overcome prior art, you are bound by that interpretation in post-grant proceedings and litigation. Avoid arguments that narrowly construe claims in ways that help during prosecution but hurt during enforcement.
- Document the technical problem and solution clearly. At the EPO, the problem-solution approach to inventive step is applied in both examination and opposition. If your prosecution arguments framed the objective technical problem in a way that does not hold up under closer scrutiny with better prior art, the opposition division will see through it.
- Avoid unnecessary admissions. Statements made during prosecution about the prior art or the scope of the invention can be used against you. Acknowledge prior art that you must address, but do not make broad concessions about the state of the art that you do not need to make.
Design Claims for Resilience
Claim structure is the single most important factor in surviving post-grant challenges. A patent with only broad independent claims and no meaningful dependent claims is fragile -- if the independent claim falls, the entire patent falls. A patent with layered claims provides fallback positions.
- Include multiple independent claims at different scope levels. Your broadest independent claim should capture the full commercial embodiment. A narrower independent claim should capture the most commercially valuable specific implementation. If the broad claim is challenged successfully, the narrow claim survives.
- Draft detailed dependent claims that add commercially relevant limitations. Dependent claims should not be throw-away claims that add trivial features. Each dependent claim should represent a meaningful fallback position that, if it becomes the broadest surviving claim, still covers the competitor's product.
- At the EPO, prepare auxiliary requests in advance. Experienced EPO practitioners draft auxiliary request claim sets during prosecution, not after opposition is filed. This ensures that fallback positions are supported by the specification and do not run afoul of Article 123(2)'s strict added matter prohibition.
Monitor and Manage Prior Art Proactively
The prior art landscape does not stop evolving when your patent is granted. New publications, newly discovered prior uses, and previously unindexed references can surface at any time. Proactive prior art monitoring allows you to anticipate challenges before they arrive.
- Conduct periodic prior art audits on your own patents. Search for prior art that could be used against your most commercially important patents. If you find problematic references, you can proactively seek claim limitation at the EPO or consider voluntary narrowing of claims to reduce vulnerability.
- Monitor competitor oppositions and IPRs. If competitors are actively challenging patents in your technology area, analyze the prior art they are using and the arguments they are making. These patterns reveal what your competitors consider effective and may indicate the prior art they would use against your patents.
- Track published prior art that emerges after your priority date. While post-priority art cannot be used to challenge novelty, it may be relevant to inventive step arguments (at the EPO, the problem-solution approach considers whether the skilled person would have been motivated to arrive at the claimed invention, which can involve post-priority publications that reflect the state of common general knowledge).
Coordinate Global Defense
A challenge in one jurisdiction often signals challenges in others. If a competitor files an EPO opposition against your European patent, you should assume they are considering (or have already filed) an IPR petition against the US counterpart and invalidation requests in Asian offices.
- Maintain consistent claim positions across jurisdictions. Arguments you make to defend claims in an EPO opposition should be consistent with the prosecution history and claim scope in the corresponding US, Japanese, Chinese, and Korean patents. Inconsistent positions create vulnerabilities that sophisticated challengers exploit through cross-jurisdictional discovery.
- Prioritize the most commercially significant jurisdiction. If resources are limited, focus your strongest defense on the jurisdiction where the patent generates the most value. A successful defense in the US and EPO may be more important than maintaining the patent in a smaller market.
- Use favorable outcomes to support defense elsewhere. A decision maintaining your patent in EPO opposition, while not binding on the PTAB or Asian offices, can be presented as persuasive authority. Similarly, a PTAB decision confirming patentability can bolster your defense in other jurisdictions.
Frequently Asked Questions
EPO Opposition
USPTO PTAB Proceedings
Strategy and Global Coordination
What's Next
This chapter covered the mechanisms for challenging and defending patents after grant -- from EPO opposition and USPTO PTAB proceedings to Asian invalidation systems and defensive prosecution strategies. Chapter 18 turns to the practical side of keeping your patents alive, covering maintenance fees, renewal deadlines, and the strategic decisions around when to maintain, narrow, or abandon patent rights across your portfolio.